Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer

BackgroundThe tumor microenvironment (TME) primarily comprises cancer cells, cancer-infiltrating immune cells, and stromal cells. The tumor cells alter the TME by secreting signaling molecules to induce immune tolerance. The immune cell infiltrating the TME influences the prognosis of patients with...

Full description

Bibliographic Details
Main Authors: Wei Wu, Xin’an Wang, Wei Le, Chang Lu, Haopeng Li, Yaru Zhu, Xi Chen, Wenbin An, Chengdang Xu, Qiang Wu, Licheng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001297/full
_version_ 1797957580201394176
author Wei Wu
Xin’an Wang
Wei Le
Chang Lu
Haopeng Li
Yaru Zhu
Xi Chen
Wenbin An
Chengdang Xu
Qiang Wu
Licheng Wang
author_facet Wei Wu
Xin’an Wang
Wei Le
Chang Lu
Haopeng Li
Yaru Zhu
Xi Chen
Wenbin An
Chengdang Xu
Qiang Wu
Licheng Wang
author_sort Wei Wu
collection DOAJ
description BackgroundThe tumor microenvironment (TME) primarily comprises cancer cells, cancer-infiltrating immune cells, and stromal cells. The tumor cells alter the TME by secreting signaling molecules to induce immune tolerance. The immune cell infiltrating the TME influences the prognosis of patients with cancers. However, immune cell infiltration (ICI) in the TME of patients with prostate cancer (PC) has not yet been studied.MethodsIn this study, we used Cell-type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT) and Estimation of Stromal and Immune cells in Malignant Tumors using Expression data (ESTIMATE) algorithms to identify three ICI clusters based on 1,099 genes associated with ICI in the TME. The patients were classified into three distinct ICI gene clusters based on overlapping differentially expressed genes in ICI clusters. Furthermore, the ICI scores were calculated using principal component analysis.ResultsThe results revealed that patients with high ICI scores had poor prognoses and reduced expression of immune-checkpoint genes and immune-related genes. Furthermore, the transforming growth factor-beta (TGF-β) and WNT-β signaling pathways were enriched in the high ICI score subgroup, which suggests that suppression of T cells could contribute to poor prognosis of patients with PC. A positive correlation was observed between the high-ICI-score subgroup and the high tumor mutation burden (TMB) value. Patients with low ICI scores could benefit from immunotherapy, indicating that the ICI score could be used to predict the efficacy of immunotherapeutic response.ConclusionsIn summary, we provide a comprehensive overview of the landscape of ICI in PC, which could aid in designing the strategies for immunotherapy for patients with PC.
first_indexed 2024-04-11T00:07:22Z
format Article
id doaj.art-1d109e1e2e1d488889b48d04f3e7abc4
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T00:07:22Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-1d109e1e2e1d488889b48d04f3e7abc42023-01-09T10:18:18ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-01-011310.3389/fimmu.2022.10012971001297Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancerWei Wu0Xin’an Wang1Wei Le2Chang Lu3Haopeng Li4Yaru Zhu5Xi Chen6Wenbin An7Chengdang Xu8Qiang Wu9Licheng Wang10Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaOrgan Transplantation Clinical Medical Center of Xiamen University, Department of Organ Transplantation, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, ChinaDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaBackgroundThe tumor microenvironment (TME) primarily comprises cancer cells, cancer-infiltrating immune cells, and stromal cells. The tumor cells alter the TME by secreting signaling molecules to induce immune tolerance. The immune cell infiltrating the TME influences the prognosis of patients with cancers. However, immune cell infiltration (ICI) in the TME of patients with prostate cancer (PC) has not yet been studied.MethodsIn this study, we used Cell-type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT) and Estimation of Stromal and Immune cells in Malignant Tumors using Expression data (ESTIMATE) algorithms to identify three ICI clusters based on 1,099 genes associated with ICI in the TME. The patients were classified into three distinct ICI gene clusters based on overlapping differentially expressed genes in ICI clusters. Furthermore, the ICI scores were calculated using principal component analysis.ResultsThe results revealed that patients with high ICI scores had poor prognoses and reduced expression of immune-checkpoint genes and immune-related genes. Furthermore, the transforming growth factor-beta (TGF-β) and WNT-β signaling pathways were enriched in the high ICI score subgroup, which suggests that suppression of T cells could contribute to poor prognosis of patients with PC. A positive correlation was observed between the high-ICI-score subgroup and the high tumor mutation burden (TMB) value. Patients with low ICI scores could benefit from immunotherapy, indicating that the ICI score could be used to predict the efficacy of immunotherapeutic response.ConclusionsIn summary, we provide a comprehensive overview of the landscape of ICI in PC, which could aid in designing the strategies for immunotherapy for patients with PC.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001297/fullprostate cancerimmune cell infiltrationtumor microenvironmentimmune checkpointtumor mutation burden
spellingShingle Wei Wu
Xin’an Wang
Wei Le
Chang Lu
Haopeng Li
Yaru Zhu
Xi Chen
Wenbin An
Chengdang Xu
Qiang Wu
Licheng Wang
Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer
Frontiers in Immunology
prostate cancer
immune cell infiltration
tumor microenvironment
immune checkpoint
tumor mutation burden
title Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer
title_full Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer
title_fullStr Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer
title_full_unstemmed Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer
title_short Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer
title_sort immune microenvironment infiltration landscape and immune related subtypes in prostate cancer
topic prostate cancer
immune cell infiltration
tumor microenvironment
immune checkpoint
tumor mutation burden
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001297/full
work_keys_str_mv AT weiwu immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer
AT xinanwang immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer
AT weile immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer
AT changlu immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer
AT haopengli immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer
AT yaruzhu immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer
AT xichen immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer
AT wenbinan immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer
AT chengdangxu immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer
AT qiangwu immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer
AT lichengwang immunemicroenvironmentinfiltrationlandscapeandimmunerelatedsubtypesinprostatecancer